Zobrazeno 1 - 10 of 27 pro vyhledávání: '"Marinos L, Tsiatas"'
3
A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer
Autor: Pinelopi, Samara, Margarita, Skopeliti, Marinos L, Tsiatas, Sylvianna, Georgaki, Charilaos, Gouloumis, Wolfgang, Voelter, Athanassios-Meletios, Dimopoulos, Aristotle, Bamias, Ourania E, Tsitsilonis
Publikováno v: Anticancer research. 36(7)
Peripheral blood mononuclear cells (PBMCs) activated with immobilized monoclonal antibody against cluster of differentiation 3 (CD3) secrete cytokines in their culture supernatant (termed ACD3S). We examined the antitumor efficacy of ACD3S-activated
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9a53fda5dd21ac5b96141d2549d875ad
https://pubmed.ncbi.nlm.nih.gov/27354596
Zobrazit plný text záznamu
4
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
Autor: Ourania E. Tsitsilonis, N. Thomakos, G. Vlahos, Ekaterini Politi, Aristidis Antsaklis, Marinos L. Tsiatas, E. Terpos, Alexandros Rodolakis, Argyrios Ziogas, Kyriaki Ioannou, Dimitrios Haidopoulos, Meletios A. Dimopoulos, Aristotle Bamias, Nikos G. Gavalas
Publikováno v: British Journal of Cancer
Angiogenesis consists a fundamental mechanism required for a number of pathophysiological processes, among others tumour growth. It constitutes a dynamic process and a high number of proangiogenic and antiangiogenic molecules have critical roles in r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00b2eb93ad31788ea1652f6f0235916
http://europepmc.org/articles/PMC3504940
Zobrazit plný text záznamu
5
Where Do Cancer Patients Die in Greece? A Population-Based Study on the Place of Death in 1993 and 2003
Autor: Kyriaki Mystakidou, Lambros Vlahos, Antonis Galanos, Elisabeth Patiraki, Eleni Tsilika, Efi Parpa, Marinos L. Tsiatas
Publikováno v: Journal of Pain and Symptom Management. 38:309-314
Several studies have shown that place of death is affected by many parameters. Our objective was to describe for the first time where patients with cancer die in Greece and what has changed between 1993 and 2003. We acquired data on all deaths that w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2e527bd4f42afa43dd37f185d05b36
https://doi.org/10.1016/j.jpainsymman.2008.09.007
Zobrazit plný text záznamu
6
The Incidence of Place of Death in Greek Patients with Cancer in 1995 and 2005
Autor: Pavlos N Theodorakis, Antonis Galanos, Marinos L. Tsiatas, Kyriaki Mystakidou, Irene Panagiotou, Eleni Tsilika, Efi Parpa
Publikováno v: American Journal of Hospice and Palliative Medicine®. 26:347-353
Purpose: To describe where (home or hospital) patients with cancer die in Greece, in 1995 and 2005. Methods: We used data from patients with cancer, who died in Greece in 1995 and 2005, and we studied the location changes of death in the 3 major geog
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ea03a7a3e94e90118dff37cc93c4f3
https://doi.org/10.1177/1049909109333932
Zobrazit plný text záznamu
7
Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome
Autor: Vasiliki Kostopoulou, Meletios-Athanasios Dimopoulos, Marinos L. Tsiatas, Christos Papadimitriou, Dimitrios A. Kelekis
Publikováno v: Emergency Radiology. 16:143-146
Port-a-cath systems are often essential for the administration of long-term chemotherapy in the treatment of malignancies because they improve venous access, but they are associated with complications, mainly thrombosis of central veins. In the prese
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7928d7588726404165ecda291c9b6659
https://doi.org/10.1007/s10140-008-0714-5
Zobrazit plný text záznamu
8
The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients
Autor: Wolfgang Voelter, Evangelia Livaniou, Ioannis F. Voutsas, Ourania E. Tsitsilonis, Monica Neagu, Alexander Beck, Aristotelis Bamias, Maria Moraki, Margarita Skopeliti, Marinos L. Tsiatas, Persefoni Klimentzou
Publikováno v: Cancer Immunology, Immunotherapy. 55:1247-1257
Prothymosin alpha (proTalpha) is a 109 amino acid long polypeptide presenting distinct immunoenhancing activity in vitro and in vivo. Recent reports suggest that in apoptotic cells, proTalpha is cleaved by caspases at its carboxy(C)-terminus generati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9c03c79891445d29a9e5dc18623ca21
https://doi.org/10.1007/s00262-005-0108-4
Zobrazit plný text záznamu
9
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics
Autor: Kyriaki Mystakidou, Emmanuela Katsouda, Efi Parpa, Marinos L. Tsiatas, Lambros Vlahos
Publikováno v: Journal of Opioid Management. 1:36-40
Breakthrough pain is a transitory flare of pain occurring in most cancer patients against a background of otherwise controlled persistent pain. Treatment of breakthrough pain is a challenging phenomenon. Oral transmucosal fentanyl citrate (Actiq ® ,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72563f6d441858bce195bc8415eed03d
https://doi.org/10.5055/jom.2005.0010
Zobrazit plný text záznamu
10
Pre-Treatment Status and Changes in Autoantibodies, Lymphocytic Populations, Cytokines and VEGF during Sunitinib Treatment of Metastatic Renal Cell Carcinoma (mRCC)
Autor: Aristotelis Bamias, Ourania E. Tsitsilonis, Eleni Sereti, Meletios A. Dimopoulos, Nikos G. Gavalas, Marinos L. Tsiatas, Alex, Eleni Karga, Paraskevi-Sofia Trachana, Evangelos Terpos, Maria Spyropoulou-Vlachou, ra Karadimou
Publikováno v: Translational Medicine.
Aims Immunotherapy has been effective in mRCC. Given the improved efficacy of anti-VEGF therapies in mRCC, their effect on the immune system emerges as a reasonable question. Methods Serum autoantibodies (aAbs), Interferon-γ (IFN-γ), Interleukins (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f0c1d7196cc32d46497b2b45a72e5b3d
https://doi.org/10.4172/2161-1025.1000124
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje